Citizens Financial Group Inc Charles River Laboratories International, Inc. Transaction History

Citizens Financial Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$175.56 - $226.45 $12,815 - $16,530	-73 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$126.05 - $152.76 $3,529 - $4,277	-28 Reduced 27.72%	73 $11,000
Q2 2019 Aug 09, 2019	BUY	$123.4 - $148.55 $6,663 - $8,021	54 Added 114.89%	101 $14,000
Q1 2019 May 09, 2019	SELL	$104.82 - $146.73 $314 - $440	-3 Reduced 6.0%	47 $7,000
Q3 2017 Nov 13, 2017	SELL	$96.72 - $109.26 $1,354 - $1,529	-14 Reduced 21.88%	50 $5,000
Q2 2017 Aug 10, 2017	BUY	N/A	64	64 $6,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.